Abstract
A system is described to evaluate for nonsteroidal antiinflammatory drugs by means of luminol-dependent human-granulocyte chemiluminescence (CL) is described. The CL is produced using either opsonized zymosan (yeast cells) or the soluble chemotactic peptide f-Met-Leu-Phe as the perturbant of the granulocyte membrane. Using either system, the following drug effects 2×10−5 M were noted: only sulindac sulfide, and not sulindac sulfone or sulindac, displayed marked inhibition of chemiluminescence, following the in vivo data regarding inflammatory effects. The 5-OH indomethacin metabolite was likewise inactive as an inhibitor of CL mirroring in vivo effects. MK(+)410, MK(−)830 and MK835 all showed approximately 50% inhibition of CL, displaying deviation from in vivo data. MK(+)830 markedly stimulated CL, 4–6 times the control (without drug), which is clearly different from its enantiomer, MK(−)830. The reasons for this behavior are unclear. However, receptor binding studies with [3H]FMLP were accomplished in the presence and absence of the various drugs at 2×105 M that were effective inhibitors of chemiluminescence (CL). Indomethacin, MK(−)830 and MK(+)410 had equivalent percent control binding and percent control CL. Sulindac sulfide and MK(+)835 both had higher percent control binding than percent control CL, with MK(+)835 displaying apparent increased numbers of available receptors relative to control. MK(+)830, which produces large increases in CL, produced a minor effect on percent control binding. A direct relationship between binding and CL does not exist with each drug. Chemiluminescence is dependent on ion movement and oxidative metabolism and is a secondary event to agonist-receptor occupation.
Similar content being viewed by others
References
Allen, R. C. 1975. Halide Dependence of the myeloperoxidase-mediated antimicrobial system of the polymorphonuclear leukocyte in the phenomenon of electronic excitation.Biochem. Biophys. Res. Commun. 63:675–683.
Egan, R. W., P. H. Gale, andR. A. Kuehl, Jr. 1979. Reduction of hyperperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase.J. Biol. Chem. 254: 3295–3302.
Higgs, G. A., R. J. Flower, andJ. R. Vane. 1979. A new approach to antiinflammatory drugs.Biochem. Pharmacol. 28:1959–1961.
Jones, G. S., K. Van Dyke, andV. Castranova. 1981. Transmembrane potential changes associated with superoxidase release from human granulocytes.J. Cell. Physiol. 106: 75–83.
Kobayashi, S., K. Sugioka, M Nakano, C. Takyu, A. Yamagishi, andH. Inaba. 1980. Excitation of indole acetate in myeloperoxidase system.Biochem. Biophys. Res. Commun. 93:967–973.
Lane, T. A., G. C. Lamkin, andB. E. Windle. 1981. Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.Blood 58:228–236.
Liao, C. S., andR. J. Freer. 1980. Cryptic receptors for chemotactic peptides in rabbit neutrophils.Biochem. Biophys. Res. Commun. 93:566–571.
Marnett, L. J., P. Wlodawer, andB. Samuelsson. 1974. Light emission during the action of prostaglandin synthetase.Biochem. Biophys. Res. Commun. 60:1286–1293.
Nakano, M., andK. Sugioka. 1977. Mechanism of chemiluminescence from the linoleatelipoxygenase system.Arch. Biochem. Biophys. 181:371–383.
Peden, D., Ch. Van Dyke, Cy. Van Dyke, K. Van Dyke, V. Castranova, G. Jones, andM. Ringrose. 1981. Arachidonate-based chemiluminescence in human granulocytes and platelets using the monolight (drug studies).In Bioluminescence and Chemiluminescence. M. A. DeLuca and W. D. McElroy, editors. Academic Press, New York. 385–390.
Duggan, D. E., K. F. Hooke, E. A. Risley, T. Y. Shen, andC. G. Van Arman. 1977. Identification of the biologically active form of sulindac.J. Pharmacol. Exp. Ther. 201:8–13.
Van Dyke, K., C. Van Dyke, D. Peden, V. Castranova, J. Udeinya, andM. J. Reasor. 1980. Inhibition of luminol-dependent chemiluminescence of human granulocytes and platelets by clinical sulfide: Possible role of unsaturated lipids in the CL response.American Society of Photobiology 8:144.
Van Dyke, K., C. Van Dyke, D. Peden, M. Matamoros, C. Castranova, andG. Jones. 1981. Preliminary events leading to production of luminol-dependent chemiluminescence by human granulocytes.In Bioluminescence and Chemiluminescence. M. A. DeLuca and W. D. McElroy, editors. Academic Press, New York. 45–62.
Van Dyke, K., C. Van Dyke, J. Udeinya, C. Brister, andM. Wilson. 1979. A new screening system based upon chemiluminescence produced from human cells (granulocytes).Clin. Chem. 25:1655–1661.
Yoshimoto, T., S. Yamamoto, K. Sugioka, M. Nakano, C. Takyu, A. Yamagishi, andH. Inaba. 1980. Studies on the tryptophan-dependent light emission by prostaglandin hydroperoxidase reaction.J. Biol. Chem. 255:10199–10204.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Dyke, K., Peden, D., Van Dyke, C. et al. Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and [3H]FMLP binding. Inflammation 6, 113–125 (1982). https://doi.org/10.1007/BF00910724
Issue Date:
DOI: https://doi.org/10.1007/BF00910724